Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Details)

v3.24.2.u1
Significant Accounting Policies (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jan. 01, 2024
Jan. 01, 2023
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Mar. 17, 2015
Significant Accounting Policies              
Issuance of common shares - Founders Agreement     $ 402 $ 396 $ 558    
Fortress Biotech, Inc              
Significant Accounting Policies              
Percentage of shares issued for offering and annual equity fee 2.50%           2.50%
Number of shares issued and sold 1,492,915 368,907   193,905 159,620    
Research and development              
Significant Accounting Policies              
Issuance of common shares - Founders Agreement           $ 3,400